2021年7月4日至9月25日俄勒冈州和华盛顿州≥12岁人群按COVID-19疫苗接种状态划分的SARS-CoV-2感染、急诊就诊及住院发生率
在美国俄勒冈州和华盛顿州一个大型整合医疗系统中,对≥12岁成员按COVID-19疫苗接种状态计算2021年7—9月实验室确诊SARS-CoV-2感染、急诊就诊和住院发生率。未接种者感染率为30.1/1000人,完成全程接种者为8.7/1000人;未接种感染者急诊就诊比例18.5%、住院比例9.0%,均高于接种者的8.1%和3.9%。数据支持CDC关于COVID-19疫苗接种(包括额外剂次和加强剂)的建议。
要点
- 未接种者SARS-CoV-2感染率30.1/1000人,高于全程接种者的8.7/1000人。
- 未接种感染者急诊就诊比例18.5%、住院比例9.0%,分别高于接种者的8.1%和3.9%。
- 未接种患者粗死亡率为0.43/1000人,高于全程接种患者的0.06/1000人。
核心结论
- 数据支持CDC关于COVID-19疫苗接种(包括额外剂次和加强剂)的建议,以保护个人和社区免受COVID-19(包括Delta变异株引起的疾病和住院)的影响。
研究设计与样本
- 在俄勒冈州和华盛顿州一个大型整合医疗系统中,对≥12岁成员按COVID-19疫苗接种状态、疫苗产品、年龄、种族和族裔计算2021年7—9月实验室确诊SARS-CoV-2感染、急诊就诊和住院的发生率。
- 全程接种后感染定义为完成授权COVID-19疫苗系列接种≥14天后SARS-CoV-2分子检测阳性。
主要发现
- 监测期间,137,616名未接种者中发生SARS-CoV-2感染4,146例(30.1/1000人),344,848名全程接种者中发生3,009例(8.7/1000人)。
- 在所有人口学分层中,未接种者的SARS-CoV-2感染发生率均高于接种者。
- 未接种的SARS-CoV-2感染者接受急诊诊疗的比例为18.5%,住院比例为9.0%,分别高于接种COVID-19者的8.1%和3.9%。
- 未接种患者的粗死亡率为0.43/1000人,高于全程接种患者的0.06/1000人。
临床怎么用
- 数据支持CDC关于COVID-19疫苗接种(包括额外剂次和加强剂)的建议,以保护个人和社区免受COVID-19(包括Delta变异株引起的疾病和住院)的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Population-based rates of infection with SARS-CoV-2 (the virus that causes COVID-19) and related health care utilization help determine estimates of COVID-19 vaccine effectiveness and averted illnesses, especially since the SARS-CoV-2 B.1.617.2 (Delta) variant began circulating in June 2021. Among members aged ≥12 years of a large integrated health care delivery system in Oregon and Washington, incidence of laboratory-confirmed SARS-CoV-2 infection, emergency department (ED) visits, and hospitalizations were calculated by COVID-19 vaccination status, vaccine product, age, race, and ethnicity. Infection after full vaccination was defined as a positive SARS-CoV-2 molecular test result ≥14 days after completion of an authorized COVID-19 vaccination series.* During the July-September 2021 surveillance period, SARS-CoV-2 infection occurred among 4,146 of 137,616 unvaccinated persons (30.1 per 1,000 persons) and 3,009 of 344,848 fully vaccinated persons (8.7 per 1,000). Incidence was higher among unvaccinated persons than among vaccinated persons across all demographic strata. Unvaccinated persons with SARS-CoV-2 infection were more than twice as likely to receive ED care (18.5%) or to be hospitalized (9.0%) than were vaccinated persons with COVID-19 (8.1% and 3.9%, respectively). The crude mortality rate was also higher among unvaccinated patients (0.43 per 1,000) than in fully vaccinated patients (0.06 per 1,000). These data support CDC recommendations for COVID-19 vaccination, including additional and booster doses, to protect individual persons and communities against COVID-19, including illness and hospitalization caused by the Delta variant (1).
引用
- Naleway AL, Groom HC, Crawford PM, et al. Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34793417. doi:10.15585/mmwr.mm7046a4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。